Skip to main content
Clinical Trials/NCT07383337
NCT07383337
Not yet recruiting
Not Applicable

A Randomized, Double-blind Crossover Pilot Trial to Compare the Olfactory Perception of a Fragrance-Loaded SpECs Over Time

Royal College of Surgeons in Ireland - Medical University of Bahrain0 sites10 target enrollmentStarted: February 15, 2026Last updated:
InterventionsFragrance

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
10
Primary Endpoint
Sustained olfactory perception over time.

Overview

Brief Summary

The human olfactory system plays a crucial role in sensory perception, influencing emotional states, memory, and interpersonal interactions(1). Fragrance durability and intensity are critical factors in the evaluation of perfumes and other scented products. The ability of fragrance formulations to maintain consistent scent intensity over time is a major contributor to a product's overall efficacy and consumer satisfaction,

Primary Aim To compare the perceived strength of a topical fragrance delivered via SpECs across a period of 8 hours using subjective ratings by participants and an independent examiner.

Objectives

  1. To investigate whether the encapsulated fragrance intensity, as perceived by participants, decreases less over time compared with fragrance alone, after application to the skin.
  2. To investigate whether the encapsulated fragrance intensity, as perceived by an independent examiner, decreases less over time compared with fragrance alone, after application to the skin.

Detailed Description

The human olfactory system plays a crucial role in sensory perception, influencing emotional states, memory, and interpersonal interactions(1). Fragrance durability and intensity are critical factors in the evaluation of perfumes and other scented products. The ability of fragrance formulations to maintain consistent scent intensity over time is a major contributor to a product's overall efficacy and consumer satisfaction.

SporoSpECsin exine capsules (SpECs), are extracted from either pollen or plant spores in the form of empty porous microcapsules penetrated by nano-diameter sized channels. These channels enable a variety of active ingredients to be loaded into the SpECs chambers; hence, giving universality to the system to encapsulate such as a variety of antibody fragments, oils and proteins and peptides. The preparation that is to be used in this study has been provided to us as a gift by Sporomex Ltd, UK that is presently being used as a cosmetic preparation commercially, and has been investigated as a taste masking agent(2) and for oral pharmaceutical delivery(3).

It is unknown if fragrance loading of these SpECs will enhance the longevity of the fragrance on the skin. This study aims to evaluate the olfactory perception of a SpECs-based fragrance delivery system over an 8-hour period. The study will compare subjective ratings of the fragrance's intensity by participants and an independent examiner. This randomized, double-blind crossover trial will provide insights into the effectiveness of SpECs as a fragrance delivery medium, while also considering the influence of skin chemistry and time on olfactory perception. By eliminating patient variability, crossover studies can be more efficient than equivalently sized parallel group trials, where each participant receives only one treatment. Hence, treatment effects can be measured with greater accuracy using the same number of participants.

Type of Study Pilot randomized, double-blind crossover trial Participants

  • Sample size: 10 female participants.

  • Inclusion criteria:

  • Females aged between 18 and 45 years.

  • No history of olfactory impairment, allergies to pollen or fragrances, or skin conditions.

  • Exclusion criteria:

  • Current use of medications that affect olfactory function (e.g., antihistamines).

  • Pregnancy or breastfeeding.

  • Any active upper respiratory tract infection within 2 weeks of the clinical trial

  • Any known skin allergy. Intervention

  • Fragrance delivery system: SpECs loaded with fragrance (50mg/ml perfume) versus fragrance without SpECs

  • Application: A smear layer of the fragrance-loaded SpECs will be applied to the wrist of each participant.

Randomization and Blinding

  • Participants will be randomized into two groups:
  1. Group A: Fragrance loaded with a concentration of SpECs grains.
  2. Group B: Fragrance loaded without SpECs grains.
  • Double-blinding: Neither the participants nor the independent examiner will know which preparation of the fragrance will be applied to the skin.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Double (Participant, Care Provider)

Masking Description

Pilot randomized, double-blind crossover trial

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Females aged between 18 and 45 years.
  • No history of olfactory impairment, allergies to pollen or fragrances, or skin conditions.

Exclusion Criteria

  • Current use of medications that affect olfactory function (e.g., antihistamines).
  • Pregnancy or breastfeeding.
  • Any active upper respiratory tract infection within 2 weeks of the clinical trial
  • Any known skin allergy.

Arms & Interventions

Group A: Fragrance loaded with a concentration of SpECs grains.

Experimental

Fragrance delivery system: SpECs loaded with fragrance (50mg/ml perfume)

Intervention: Fragrance (Other)

Group B: Fragrance loaded without SpECs grains

Active Comparator

fragrance without SpECs

Intervention: Fragrance (Other)

Outcomes

Primary Outcomes

Sustained olfactory perception over time.

Time Frame: 6 hour period- 4 timepoints

The study will determine whether fragrance-loaded SpECs provides a sustained olfactory perception over time.

Secondary Outcomes

  • Impact of SpECs concentration on fragrance(6 hour period- 4 timepoints)
  • alignment between participant's and independent examiner's ratings(6 hour period- 4 timepoints)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials